To date, $70 million is the highest award to a Plaintiff in the Philadelphia Risperdal litigation. Read more
Risperdal went on the market in 1993 after receiving approval from the FDA for the treatment of schizophrenia. Read more
In November, another jury awarded $1.75 million to a Maryland man who took Risperdal as a 9-year-old in 2003. Read more
To date, there have been four Risperdal trials in Philadelphia. Read more
Johnson & Johnson was once a well-respected company in this country and in many circles it still is. But based on our firm’s litigation experience with this company, I am convinced that... Read more
Jansen Pharmaceuticals is fighting to keep Risperdal litigation in a federal court. Read more
There are more than 1,600 Risperdal cases pending as part of a mass tort program in the court. Read more
The tribe alleged in its suit that it had bought Risperdal between March 3, 2002, and Dec. 31, 2003, a period during which the companies admitted to misbranding the drug as part of a plea de... Read more
Lawyers in the Mass Torts Section at Beasley Allen continue to pursue Risperdal claims on behalf of individuals who have been injured as a result of taking Risperdal, the brand name drug man... Read more
The South Carolina Supreme Court has further reduced the judgment against Ortho-McNeil-Janssen Pharmaceuticals Inc., a Johnson & Johnson subsidiary, in the state’s suit over decept... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.